Funding: French retinal implant maker Pixium Vision raises $20M
Paris-based Pixium Vision touts a $23.3 million (€15 million) Series A funding round in support of its IRIS retinal implant for treatment of vision-loss due to degenerative eye conditions.
Retinal implants maker Pixium landed a $20.3 million (€15 million) Series A funding round, planning to use the funds to further develop its IRIS "bionic eye" technology.
The IRIS system is comprised of a retinal implant and a pair of camera-mounted glasses connected to a "pocket computer." The computer processes images captured by the glasses and transmits the data into a signal that's transferred back and projected onto the intraocular implant, where it stimulates the optic nerve and generates images that the brain learns to interpret as visual signals.